Eterna Therapeutics
ERNA
#11171
Rank
NZ$4.2 M
Marketcap
NZ$2.49
Share price
-16.56%
Change (1 day)
3.41%
Change (1 year)

Earnings for Eterna Therapeutics (ERNA)

Earnings in 2026 (TTM): -NZ$28.71 Million

According to Eterna Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$25.78 Million, an increase over its 2024 earnings that were of -NZ$69.27 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eterna Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$28.71 Million11.36%
2025 -NZ$25.78 Million-62.78%
2024 -NZ$69.27 Million84.63%
2023 -NZ$37.52 Million-16.24%
2022 -NZ$44.79 Million-80.08%
2021 -NZ$0.23 Billion1596.7%
2020 -NZ$13.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
NZ$14.23 B-47,243.04%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-NZ$0.35 Billion 1,031.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
NZ$29.2 M-196.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-NZ$34.8 Million 15.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-NZ$7.07 Million-76.61%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
NZ$2.23 B-7,509.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
NZ$0.45 B-1,615.19%๐Ÿ‡บ๐Ÿ‡ธ USA